AOD-9604 5mg

AOD-9604, or Anti-Obesity Drug-9604, is a synthetic peptide developed initially for its potential in the treatment of obesity. It is a modified form of the human growth hormone (hGH) fragment encompassing amino acids 176-191 at the C-terminus of the hormone. This peptide was designed to mimic the fat-burning properties of hGH without its muscle-building effects or other hGH-associated side effects.

The development of AOD-9604 stems from research into the lipolytic (fat-burning) effects of hGH. Scientists discovered that a specific region of the growth hormone molecule is responsible for its fat-reducing properties. AOD-9604 was created by isolating and modifying this fragment to maximize its potential for weight loss and fat metabolism.

In terms of mechanism, AOD-9604 stimulates lipolysis – the breakdown of fats and lipids – and inhibits lipogenesis, the transformation of non-fat food materials into body fat. Unlike hGH, AOD-9604 does not have an impact on growth or insulin resistance. It is believed to mimic the way natural growth hormone regulates fat metabolism but without the adverse effects on blood sugar or growth that is seen with unmodified hGH.

Clinical trials of AOD-9604 have shown mixed results in terms of its efficacy in obesity treatment. While some studies have indicated potential benefits in terms of fat reduction and weight loss, others have not found significant effects. As a result, AOD-9604 has not received approval from regulatory bodies like the FDA for the treatment of obesity.

In comparison to other weight-loss drugs like Semaglutide and Tirzepatide, which influence appetite and insulin secretion, AOD-9604's action is more focused on fat metabolism. However, its clinical utility is still under investigation, and it remains a research chemical rather than a widely accepted pharmaceutical treatment for obesity.

Its use has also been explored in the context of bodybuilding and athletic performance, primarily for its purported fat-burning properties, though such uses are not supported by clinical studies and are not recognized by regulatory health authorities.

Check out Jay Campbell's website, which is an excellent source for peptide research.